AusPAR: Dazalex SC
Australian Public Assessment Report
Device/Product Name
Darzalex SC
Active ingredients
Daratumumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-04809-1-6
Submission Type
Extension of indications
Decision
Approved